Orgenesis Inc. (ORGS) financial statements (2021 and earlier)

Company profile

Business Address 20271 GOLDENROD LANE
GERMANTOWN, MD 20876
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
11/30/2018
11/30/2017
11/30/2016
11/30/2015
11/30/2014
11/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments111641410
Cash and cash equivalents111641410
Receivables1151111 
Inventory, net of allowances, customer advances and progress billings22100 
Inventory22100  
Prepaid expense1111100
Deposits current assets      0
Other undisclosed current assets17211  
Total current assets:263074820
Noncurrent Assets
Operating lease, right-of-use asset10
Property, plant and equipment241255400
Long-term investments and receivables31     
Due from related parties31     
Intangible assets, net (including goodwill)2932262526 
Goodwill1515111010  
Intangible assets, net (excluding goodwill)1417151517  
Derivative instruments and hedges  0    
Deposits noncurrent assets10     
Other noncurrent assets00000  
Prepaid pension costs  00
Other undisclosed noncurrent assets  100  
Total noncurrent assets:674533293100
TOTAL ASSETS:927540333920
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17987621
Accounts payable11445310
Accrued liabilities2211100
Employee-related liabilities4332110
Deferred revenue9
Debt4134620
Derivative instruments and hedges, liabilities   02  
Due to related parties  00000
Deferred revenue and credits411  
Other undisclosed current liabilities272220 
Total current liabilities:321717151651
Noncurrent Liabilities
Long-term debt and lease obligation22351   
Long-term debt, excluding current maturities13351   
Finance lease, liability1
Operating lease, liability8
Liabilities, other than long-term debt010000 
Liability, pension and other postretirement and postemployment benefits000000
Other liabilities01     
Derivative instruments and hedges, liabilities   0   
Other undisclosed noncurrent liabilities2217711
Total noncurrent liabilities:24658711
Total liabilities:552322232452
Stockholders' equity
Stockholders' equity attributable to parent, including:5281411(6)(3)(2)
Common stock0000000
Common stock, share subscribed but unissued, subscriptions receivable 21 10 
Additional paid in capital9588554214139
Accumulated other comprehensive income (loss)001(1)(1)(0) 
Accumulated deficit(89)(62)(44)(30)(21)(16) 
Warrants and rights outstanding     11
Other undisclosed stockholders' equity attributable to parent     (1)(12)
Stockholders' equity attributable to noncontrolling interest10     
Other undisclosed stockholders' equity  4 21  
Total stockholders' equity:629181115(3)(2)
Other undisclosed liabilities and equity3124     
TOTAL LIABILITIES AND EQUITY:927540333920

Income statement (P&L) ($ in millions)

12/31/2019
11/30/2018
11/30/2017
11/30/2016
11/30/2015
11/30/2014
11/30/2013
Revenues33191063  
Other operating income03     
Cost of revenue(18)(11)(7)(8)(4)  
Gross profit:1583(1)(1)  
Operating expenses(38)(23)(12)(8)(6)(5)(5)
Other undisclosed operating income (loss)(2)0(3)(2)   
Operating loss:(25)(15)(11)(11)(7)(5)(5)
Nonoperating income (expense)(1)(3)(2)12(1)(0)
Investment income, nonoperating   (0)   
Debt instrument, convertible, beneficial conversion feature     0 
Other nonoperating income (expense)(1)(3)(2)12(1)(0)
Interest and debt expense(0)(3)(1)(0)(1)(1) 
Other undisclosed income from continuing operations before equity method investments, income taxes0310120
Loss from continuing operations before income taxes:(25)(18)(14)(11)(5)(5)(5)
Income tax expense (benefit)(1)(1)121  
Net loss:(26)(19)(12)(9)(4)(5)(5)
Net income attributable to noncontrolling interest21     
Other undisclosed net loss attributable to parent     (1)(0)
Net loss attributable to parent:(24)(18)(12)(9)(4)(6)(6)
Other undisclosed net income (loss) available to common stockholders, basic(4)37     
Net income (loss) available to common stockholders, basic:(28)19(12)(9)(4)(6)(6)
Interest on convertible debt 0     
Net income (loss) available to common stockholders, diluted:(28)20(12)(9)(4)(6)(6)

Comprehensive Income ($ in millions)

12/31/2019
11/30/2018
11/30/2017
11/30/2016
11/30/2015
11/30/2014
11/30/2013
Net loss:(26)(19)(12)(9)(4)(5)(5)
Other comprehensive loss(25)(19)     
Other undisclosed comprehensive income2418     
Comprehensive loss:(26)(20)(12)(9)(4)(5)(5)
Comprehensive income, net of tax, attributable to noncontrolling interest21     
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  30(1)(1)(0)
Comprehensive loss, net of tax, attributable to parent:(25)(19)(10)(9)(6)(6)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: